Call us at (866) 334-3006 or book a consultation online
MDLs allow several similar lawsuits to be consolidated into a single litigation, expediting the legal process
Without insurance, both brand-name medications are expensive typically $900 to $1,400 per month at retail price
Furthermore, when individual skin lesions don't respond to a treatment in the normal, timely manner the original diagnosis should be re-considered
Here we compare the published data from the STEP-1, SURMOUNT-1, and TRIUMPH-4 trials without marketing spin: -14,9% for semaglutide, -20,9% for the tirzepatide-28,7% for the retatrutideThe retatrutide vs tirzepatide vs semaglutide comparison also incorporates tolerance (dysesthesia 20,9% at the 12 mg dose level of retatrutide), pleiotropic effects 2024-2025 (apnea, heart failure, MASLD), and the updated regulatory status in France 2026